| 发明名称 |
Use of 5ht3-receptor antagonists for the treatment of chronic fatiguesyndrome |
| 摘要 |
A method of treatment for Chronic Fatigue Syndrome (CFS) comprising reducing the effect of serotonin by administering a dosage unit comprised of 5HT3-receptor-antagonist in an amount effective to decrease the effect of serotonin. |
| 申请公布号 |
AU2428500(A) |
申请公布日期 |
2000.07.12 |
| 申请号 |
AU20000024285 |
申请日期 |
1999.12.22 |
| 申请人 |
NOVARTIS PHARMA GMBH |
发明人 |
DIETER WELZEL |
| 分类号 |
A61K45/00;A61K31/415;A61K31/4178;A61K31/439;A61K31/46;A61P3/02;A61P11/04;A61P19/02;A61P21/00;A61P25/20;A61P29/00;A61P43/00 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
